Very interesting read, thanks for posting!
I'm not sure how I feel about the whole subject.......On one hand I'm glad the CFF is profiting because they can turn around and put money back into research. On the other side of the coin, I also wish that Kalydeco was more affordable, and wonder about the CFF turning a profit. Overall though, I think it's a good thing that the CFF is pioneering new ways to get research companies to work on drugs for CF. We've been overlooked for so long due to our small population, without the CFF's work these new (VERY exciting) drugs would not be in the pipeline and Kalydeco would not have came to market. On the flip side though, if they are so expensive that very few can afford them, then it makes you wonder. Like I said, complex issue and now I'm confusing myself, so I'll sign off here...
Take CAre,
Autumn 32 w/CF